Moreover, the study showed that treatment with ceramide liposomes, which are believed to have multiple activities against the progression of ovarian cancer, reduced cell migration by affecting PIK3C2B compartmentalization. The gene discussed is PIK3C2B; the disease is ovarian cancer.